Navigation path

About FP5 Funding

European Research Programme on HIV/AIDS, Malaria and Tuberculosis (1998-2002)

In the period from 1998 to 2002, under the Fifth Framework Programme for Research and Technological Development, Quality of Life and Management of Living Resources Programme, the Commission has made substantial investments in a broad range of research activities related to HIV/AIDS, Malaria and TB. Over €109 million has been committed to research on these three poverty-related diseases. A total of 77 projects were supported: 32 of these on HIV/AIDS, 24 on malaria and 21 on tuberculosis. Vaccine research accounted for 56% of the total budget, 31% for drug discovery and research and 13% for research on health policy and health systems. A detailed description of the budget allocated to these research areas for the 3 diseases is reported in figures 1 and 2. These research projects have involved about 500 research institutions in total, from 21 countries in Europe, 21 in Africa, 11 in Latin America, 7 in Asia and the USA, as well as from 18 industries.

Fig. 1. Budget allocation corresponding to the diseases and to the type of research during the 5th Framework Programme for Research and Technology Development.
Fig. 2. Budget allocation corresponding to the diseases subdivided between the two FP5 Programmes: Quality of Life Programme (QoL, Key Action 2 "Control of Infectious Diseases") and International Cooperation Programme (INCO)

A compilation of Quality of Life Publications is available at the websites: